This $14 Billion Meme Stock Says It Is Developing a Herbal Remedy for Autism
Regencell Bioscience(US:RGC) WSJ·2026-01-27 10:30Core Viewpoint - The Nasdaq-listed company is experiencing recurring losses and has no revenue [1] Group 1 - The company is listed on the Nasdaq stock exchange [1] - The company has been reporting consistent financial losses [1] - The company currently does not generate any revenue [1]